Alternative Bio (ABio)
Develops precision medicines targeting protein synthesis for breakthrough cancer therapies.
F-Prime Team
Sector
Life SciencesCategory
TherapeuticsLocation
SingaporeInitial Investment
2022
Develops precision medicines targeting protein synthesis for breakthrough cancer therapies.
Alternative Bio’s mission is to translate the discovery of novel protein synthesis regulatory nodes into first-in-class precision medicines to treat the most challenging cancers. The company’s vision is to establish itself as a global pioneer in this new research space as it advances breakthrough therapies to benefit cancer patients worldwide.